Does ALEMTUZUMAB Cause Haemoptysis? 119 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Haemoptysis have been filed in association with ALEMTUZUMAB (Campath). This represents 0.8% of all adverse event reports for ALEMTUZUMAB.
119
Reports of Haemoptysis with ALEMTUZUMAB
0.8%
of all ALEMTUZUMAB reports
7
Deaths
91
Hospitalizations
How Dangerous Is Haemoptysis From ALEMTUZUMAB?
Of the 119 reports, 7 (5.9%) resulted in death, 91 (76.5%) required hospitalization, and 10 (8.4%) were considered life-threatening.
Is Haemoptysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Haemoptysis?
RIVAROXABAN (1,961)
ASPIRIN (1,255)
APIXABAN (846)
TREPROSTINIL (838)
ALBUTEROL (652)
CLOPIDOGREL BISULFATE (643)
PREDNISONE (618)
WARFARIN (555)
ADALIMUMAB (472)
TIOTROPIUM (462)
Which ALEMTUZUMAB Alternatives Have Lower Haemoptysis Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET